Ligand validation:7KEQ

NXL: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide

NXL is a Ligand Of Interest in 7KEQ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7KEQ_NXL_A_401	44%	32%	0.19	0.917	0.99	1.7	1	3	0	0	100%	1
7MEB_NXL_A_401	78%	25%	0.113	0.957	1.15	1.9	2	7	0	0	100%	0.68
7MEC_NXL_A_401	74%	31%	0.112	0.942	1.21	1.54	2	3	0	0	100%	0.86
7KER_NXL_A_401	72%	41%	0.145	0.971	1.17	1.12	2	2	1	0	100%	1
7LNQ_NXL_A_401	71%	29%	0.123	0.943	1.16	1.65	2	5	0	0	100%	0.83
7KEP_NXL_A_401	68%	30%	0.142	0.953	1.06	1.73	1	4	0	0	100%	0.87
9ORH_NXL_B_301	100%	40%	0.034	0.99	0.47	1.85	-	4	1	0	100%	0.84
4HBU_NXL_A_301	100%	51%	0.04	0.993	0.56	1.31	-	1	2	0	100%	1
9ORS_NXL_B_301	100%	43%	0.038	0.987	0.49	1.69	-	2	0	0	100%	0.82
9IL9_NXL_A_301	100%	20%	0.042	0.983	1.84	1.52	1	4	1	0	100%	1
9BZQ_NXL_A_401	99%	38%	0.059	0.986	1.51	0.93	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.